Why and how to quantify minimal residual disease in acute lymphoblastic leukemia?

Research output: Contribution to journal › Article › Academic › peer-review

117 Citations (Scopus)

Research programs

@article{70c2308734e049c1b02e5bbf8cd4ebc7,

title = "Why and how to quantify minimal residual disease in acute lymphoblastic leukemia?",

author = "Tomek Szczepanski",

year = "2007",

doi = "10.1038/sj.leu.2404603",

language = "Undefined/Unknown",

volume = "21",

pages = "622--626",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "4",

}